139 related articles for article (PubMed ID: 25396293)
1. Pharmacodynamic and clinical implications of switching between P2Y12 receptor antagonists: considerations for practice.
Bagai A; Chua D; Cohen EA; Saw J; Verma S; Vijayaraghavan R; Welsh R; Fitchett D
Crit Pathw Cardiol; 2014 Dec; 13(4):156-8. PubMed ID: 25396293
[TBL] [Abstract][Full Text] [Related]
2. Contemporary antithrombotic strategies in patients with acute coronary syndrome admitted to cardiac care units in Italy: The EYESHOT Study.
De Luca L; Leonardi S; Cavallini C; Lucci D; Musumeci G; Caporale R; Abrignani MG; Lupi A; Rakar S; Gulizia MM; Bovenzi FM; De Servi S;
Eur Heart J Acute Cardiovasc Care; 2015 Oct; 4(5):441-52. PubMed ID: 25414322
[TBL] [Abstract][Full Text] [Related]
3. In-hospital switching between adenosine diphosphate receptor inhibitors in patients with acute myocardial infarction treated with percutaneous coronary intervention: Insights into contemporary practice from the TRANSLATE-ACS study.
Bagai A; Peterson ED; Honeycutt E; Effron MB; Cohen DJ; Goodman SG; Anstrom KJ; Gupta A; Messenger JC; Wang TY
Eur Heart J Acute Cardiovasc Care; 2015 Dec; 4(6):499-508. PubMed ID: 25515725
[TBL] [Abstract][Full Text] [Related]
4. A pharmacodynamic comparison of 5 anti-platelet protocols in patients with ST-elevation myocardial infarction undergoing primary PCI.
Koul S; Andell P; Martinsson A; Smith JG; Scherstén F; Harnek J; Götberg M; Norström E; Björnsson S; Erlinge D
BMC Cardiovasc Disord; 2014 Dec; 14():189. PubMed ID: 25516485
[TBL] [Abstract][Full Text] [Related]
5. Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents.
Mauri L; Kereiakes DJ; Yeh RW; Driscoll-Shempp P; Cutlip DE; Steg PG; Normand SL; Braunwald E; Wiviott SD; Cohen DJ; Holmes DR; Krucoff MW; Hermiller J; Dauerman HL; Simon DI; Kandzari DE; Garratt KN; Lee DP; Pow TK; Ver Lee P; Rinaldi MJ; Massaro JM;
N Engl J Med; 2014 Dec; 371(23):2155-66. PubMed ID: 25399658
[TBL] [Abstract][Full Text] [Related]
6. Antiplatelet and anticoagulation agents in acute coronary syndromes: what is the current status and what does the future hold?
Huber K; Bates ER; Valgimigli M; Wallentin L; Kristensen SD; Anderson JL; Lopez Sendon JL; Tubaro M; Granger CB; Bode C; Ohman EM; Steg PG
Am Heart J; 2014 Nov; 168(5):611-21. PubMed ID: 25440788
[TBL] [Abstract][Full Text] [Related]
7. Occurrence, causes, and outcome after switching from ticagrelor to clopidogrel in a real-life scenario: data from a prospective registry.
Biscaglia S; Campo G; Pavasini R; Tebaldi M; Tumscitz C; Ferrari R
Platelets; 2016 Jul; 27(5):484-7. PubMed ID: 27050796
[TBL] [Abstract][Full Text] [Related]
8. Developments in Oral Antiplatelet Agents for the Treatment of Acute Coronary Syndromes: Clopidogrel, Prasugrel, and Ticagrelor.
Roffman DS
J Pharm Pract; 2016 Jun; 29(3):239-49. PubMed ID: 25660584
[TBL] [Abstract][Full Text] [Related]
9. Platelet Inhibition Agents: Current and Future P2Y12 Receptor Antagonists.
Tang J; Li MP; Zhou HH; Chen XP
Curr Vasc Pharmacol; 2015; 13(5):566-77. PubMed ID: 25440595
[TBL] [Abstract][Full Text] [Related]
10. Effect of prasugrel pre-treatment strategy in patients undergoing percutaneous coronary intervention for NSTEMI: the ACCOAST-PCI study.
Montalescot G; Collet JP; Ecollan P; Bolognese L; Ten Berg J; Dudek D; Hamm C; Widimsky P; Tanguay JF; Goldstein P; Brown E; Miller DL; LeNarz L; Vicaut E;
J Am Coll Cardiol; 2014 Dec; 64(24):2563-2571. PubMed ID: 25524333
[TBL] [Abstract][Full Text] [Related]
11. Bleeding risk and incidence in real world percutaneous coronary intervention patients with ticagrelor.
Subiakto I; Asrar ul Haq M; Van Gaal WJ
Heart Lung Circ; 2015 Apr; 24(4):404-6. PubMed ID: 25465512
[No Abstract] [Full Text] [Related]
12. Prasugrel hydrochloride for the treatment of acute coronary syndromes.
Lhermusier T; Waksman R
Expert Opin Pharmacother; 2015 Mar; 16(4):585-96. PubMed ID: 25633751
[TBL] [Abstract][Full Text] [Related]
13. Economic evaluation of ticagrelor for secondary prevention following acute coronary syndromes.
Gouveia M; Borges M; Trindade R; Rikner K
Rev Port Cardiol; 2015 Jan; 34(1):17-25. PubMed ID: 25528973
[TBL] [Abstract][Full Text] [Related]
14. Circulating reticulated platelets over time in patients with myocardial infarction treated with prasugrel or ticagrelor.
Eisen A; Lerman-Shivek H; Perl L; Rechavia E; Leshem-Lev D; Zemer-Wassercug N; Dadush O; Kazum S; Codner P; Kornowski R; Lev EI
J Thromb Thrombolysis; 2015 Jul; 40(1):70-5. PubMed ID: 25481810
[TBL] [Abstract][Full Text] [Related]
15. Increased uptake of guideline-recommended oral antiplatelet therapy: insights from the Canadian acute coronary syndrome reflective.
Gandhi S; Zile B; Tan MK; Saranu J; Bucci C; Yan AT; Robertson P; Quantz MA; Letovsky E; Tanguay JF; Dery JP; Fitchett D; Madan M; Cantor WJ; Heffernan M; Natarajan MK; Wong GC; Welsh RC; Goodman SG;
Can J Cardiol; 2014 Dec; 30(12):1725-31. PubMed ID: 25475475
[TBL] [Abstract][Full Text] [Related]
16. Is clopidogrel better than aspirin following breakthrough strokes while on aspirin? A retrospective cohort study.
Lee M; Wu YL; Saver JL; Lee HC; Lee JD; Chang KC; Wu CY; Lee TH; Wang HH; Rao NM; Ovbiagele B
BMJ Open; 2014 Dec; 4(12):e006672. PubMed ID: 25468508
[TBL] [Abstract][Full Text] [Related]
17. Concomitant use of warfarin and ticagrelor as an alternative to triple antithrombotic therapy after an acute coronary syndrome.
Braun OÖ; Bico B; Chaudhry U; Wagner H; Koul S; Tydén P; Scherstén F; Jovinge S; Svensson PJ; Gustav Smith J; van der Pals J
Thromb Res; 2015 Jan; 135(1):26-30. PubMed ID: 25467434
[TBL] [Abstract][Full Text] [Related]
18. Early Referral to Coronary Artery Bypass Grafting Following Acute Coronary Syndrome, Trends and Outcomes from the Acute Coronary Syndrome Israeli Survey (ACSIS) 2000-2010.
Klempfner R; Barac YD; Younis A; Kopel E; Younis A; Ronen G; Maor E; Arbel Y; Rott D; Goldenberg I; Aravot D
Heart Lung Circ; 2018 Feb; 27(2):175-182. PubMed ID: 28325709
[TBL] [Abstract][Full Text] [Related]
19. Switching of platelet P2Y12 receptor inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention: Review of the literature and practical considerations.
De Luca L; Capranzano P; Patti G; Parodi G
Am Heart J; 2016 Jun; 176():44-52. PubMed ID: 27264219
[TBL] [Abstract][Full Text] [Related]
20. Switching P2Y12-receptor inhibitors in patients with coronary artery disease.
Rollini F; Franchi F; Angiolillo DJ
Nat Rev Cardiol; 2016 Jan; 13(1):11-27. PubMed ID: 26283269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
